Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma
Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate PFS of gemcitabine,vincristine and
cisplatin as second line therapy in patients with sarcoma. 40 patients will be treated into
this study.